Our findings indicate that systemic, transient activation of IRE1/XBP1s signaling engenders multi-tissue benefits that integrate to mitigate obesity-driven metabolic dysfunction. This evidence concerns the gene ERN1 and obesity due to melanocortin 4 receptor deficiency.